It is the short-cut for sure.
FDA dont usually suggest a Ph2b/3 right after Ph1b/2a, given the sample size of RAD101 trial history.
Sometimes they still require a complete Ph2 to test on patient in different doses.
- Forums
- ASX - By Stock
- RAD
- Ann: FDA Pre-IND meeting supports an IND application for RAD 101
Ann: FDA Pre-IND meeting supports an IND application for RAD 101, page-4
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAD (ASX) to my watchlist
|
|||||
Last
3.4¢ |
Change
-0.003(8.11%) |
Mkt cap ! $37.01M |
Open | High | Low | Value | Volume |
3.5¢ | 3.6¢ | 3.4¢ | $75.34K | 2.148M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 84368 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 261529 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 84368 | 0.035 |
5 | 1307132 | 0.034 |
4 | 1116000 | 0.033 |
1 | 200000 | 0.032 |
7 | 537563 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 499988 | 10 |
0.037 | 216500 | 1 |
0.038 | 245162 | 4 |
0.039 | 391931 | 2 |
0.040 | 630704 | 5 |
Last trade - 11.02am 20/08/2024 (20 minute delay) ? |
Featured News
RAD (ASX) Chart |